Group items tagged

 MedlineRanker is free for use and is available at http://cbdm.mdc-berlin.de/tools/medlineranker.

Review of Zotero, Mendeley, CiteULike, Connotea, RefWorks, and EndNoteWeb. Brief hyperlinked mentions of 2collab, Labmeeting, Reference Manager, Citavi, Papers, JabRef, and tools for managing BibTeX files.

Review of Zotero, Mendeley, CiteULike, Connotea, RefWorks, and EndNoteWeb. Brief hyperlinked mentions of 2collab, Labmeeting, Reference Manager, Citavi, Papers, JabRef, and tools for managing BibTeX files.

Natural Standard Herbal Pharmacotherapy: An Evidence-Based Approach is now available for purchase. The book provides practical guidance on the use of herbal therapies for medical conditions. This reference tool will be an essential part of herbal pharmacy core curricula for all healthcare disciplines. Chapters are organized by medical condition and present supportive evidence, including potential mechanisms of action and dosing, for selected herbal therapies. The chapters also include integrative therapy plans to help clinicians quickly assess patient needs and create cohesive treatment plans. In addition, adjunct therapies, including herbs, supplements and modalities, that are commonly used in combination with primary treatments are discussed. Case studies, which summarize efficacy, safety, dosing and interactions for high-utilization products, help prepare healthcare providers for patient counseling in clinical practice. Review questions, similar to those on national board exams, allow readers to evaluate their learning and identify areas for further study. The book also includes several appendices, which provide information about lab values as well as the safety, interactions and pharmacokinetics of select herbs.

Medical Conditions, Genomics + Proteomics, Comparative Effectiveness, Environmental + Global Health, Nutriceuticals, Interactive Tools, Monographs, Blogs, Webinars, Calculators, Podcasts, News

The Scientist published that "Merck paid an undisclosed sum to Elsevier to produce several volumes of a publication that had the look of a peer-reviewed medical journal, but contained only reprinted or summarized articles--most of which presented data favorable to Merck products--that appeared to act solely as marketing tools with no disclosure of company sponsorship. "

Patient empowerment, advocacy, medical consumerism and tools to navigate the dysfunction of American health care.

David Rothman, academic/medical librarian, created this comprehensive search tool for nonprofessional medical researchers with Google's Custom Search Engine (CSE).

Government portal for the CDC. Provides medical and health care information, research, policies, reports, agencies, experts, tools, resources, contacts, and news.

Reference portal largely directed at medical professionals and health care providers, this site has articles, clinical guidelines, workups, drug databases, algorithms, CMEs, and other educational tools and resources.

A resource largely for patients and non-professional consumers of medicine and health care, created by the Mayo Clinic as an educational tool to help facilitate delivery of better, more efficient medicine to informed, participatory clients.

Access research studies, publications, conference proceedings, reference materials, databases, tools, and other resources of interest to medical researchers, health care providers, patients, consumers, citizens, and policymakers.

There is reasonable evidence that the use of imiquimod for small (<2 cm) superficial BCC that occur other than on the face provides outcomes only marginally less satisfactory than surgery. There would be a place for imiquimod in treating patients with frequent multiple primary lesions when access to surgery is difficult or where clinical judgment may be influenced by patient factors as reported in some of the studies, eg, where patients may have contraindications to surgery.  It was noted that if recurrences occurred in this study they mostly occurred during the first 9 months after the end of treatment. The initial response was therefore predictive of long-term outcome so these authors recommend and encourage continued monitoring of skin lesions.

For patients without comorbidities, our study revealed good cure rates for superficial BCC and superficial/nodular BCC (88% and 85%, respectively). Nodular and aggressive BCC and Bowen's disease exhibited lower cure rates (50%, 50%, and 57%, respectively). I

Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial